Among adults with COPD, the likelihood for having mucus plugs on CT can be determined using a tool that considers 11 “readily ...

Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...

Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.

Researchers may have found a new target in chronic obstructive pulmonary disease (COPD) symptoms that could potentially save more lives. The study focused on mucus plugs, which clog airways in the ...

WASHINGTON -- Dupilumab (Dupixent) reduced airway inflammation and increased lung capacity in patients with uncontrolled, moderate-to-severe asthma, while also reducing troublesome mucus plugs, a ...

Researchers found that fewer dupilumab-receiving patients had high mucus plug scores at week 24 than at baseline (32.8 vs 67.2%). HealthDay News — Dupilumab reduces mucus plug scores and improves lung ...

WASHINGTON -- Mucus plugs obstructing the airways of patients with chronic obstructive pulmonary disease (COPD) were associated with higher all-cause mortality compared with no mucus plugs, according ...

Patients with poorly controlled asthma and mucus plugs had significantly more airflow obstruction, type 2 inflammation and severe exacerbations, according to a study published in The Journal of ...

A retrospective analysis of patient data from the COPDGene study suggests that targeting mucus plugs could help prevent deaths from chronic obstructive pulmonary disease - the fourth leading cause of ...

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, most often caused by cigarette smoking or long-term exposure to air pollutants. While there is ...

Blessing Azeke wrapped her cardigan around her body as another asthma attack set in. Provoked by cold air from an overhead fan in her law school classroom in Enugu, Nigeria, her lungs refused to let ...